Form 8-K - Current report:
SEC Accession No. 0001437749-19-012278
Filing Date
2019-06-19
Accepted
2019-06-19 16:05:27
Documents
29
Period of Report
2019-06-19
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20190619_8k.htm 8-K 28595
2 EXHIBIT 99.1 ex_147963.htm EX-99.1 23623
3 EXHIBIT 99.2 ex_147964.htm EX-99.2 14804
4 a01.jpg GRAPHIC 228710
5 a02.jpg GRAPHIC 274137
6 a03.jpg GRAPHIC 46449
7 a04.jpg GRAPHIC 144917
8 a05.jpg GRAPHIC 207819
9 a06.jpg GRAPHIC 242853
10 a07.jpg GRAPHIC 53113
11 a08.jpg GRAPHIC 152216
12 a09.jpg GRAPHIC 180316
13 a10.jpg GRAPHIC 170346
14 a11.jpg GRAPHIC 114024
15 a12.jpg GRAPHIC 156209
16 a13.jpg GRAPHIC 111367
17 a14.jpg GRAPHIC 126283
18 a15.jpg GRAPHIC 228381
19 a16.jpg GRAPHIC 22756
20 a17.jpg GRAPHIC 207441
21 a18.jpg GRAPHIC 206726
22 a19.jpg GRAPHIC 239824
23 a20.jpg GRAPHIC 20910
24 a21.jpg GRAPHIC 145235
25 a22.jpg GRAPHIC 177983
26 a23.jpg GRAPHIC 171943
27 a24.jpg GRAPHIC 121729
28 a25.jpg GRAPHIC 254728
29 logo01.jpg GRAPHIC 18167
  Complete submission text file 0001437749-19-012278.txt   5578630
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 19906113
SIC: 2834 Pharmaceutical Preparations